Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: Development and validation of a predictive model

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Jung, Kyu Sik ^a   Kim, Ji Hong ^a   Kim, Seung Up ^a,b   Song, Kijun ^a   Kim, Beom Kyung ^a,b   Park, Jun Yong ^a,b   Kim, Do Young ^a,b   Ahn, Sang Hoon ^a,b   Moon, Do Chang ^a   Song, In Ji ^a   Choi, Gi Hong ^a   Park, Young Nyun ^a   Han, Kwang Hyub ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BOOTSTRAPPING; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; ELASTOGRAPHY; FEMALE; HEPATOBILIARY PARAMETERS; HUMAN; LIVER CELL CARCINOMA; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; VALIDATION STUDY; AGED; CANCER GRADING; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; FOLLOW UP; LIVER; LIVER NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84902602772     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099167     Document Type: Article

References (41)

1. Llovet JM, Schwartz M, Mazzaferro V (2005) Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 25: 181-200. (Pubitemid 40781071)
2. Tung-Ping Poon R, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232: 10-24.
3. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, et al. (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 89: 500-507. (Pubitemid 30640096)
4. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, et al. (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 38: 200-207. (Pubitemid 36169630)
5. Qu LS, Jin F, Huang XW, Shen XZ (2010) High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection. J Gastrointest Surg. 14: 1111-1120. Epub 2010 Apr 1127.
6. Sasaki Y, Imaoka S, Masutani S, Ohashi I, Ishikawa O, et al. (1992) Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery 112: 515-521.
7. Kim SU, Ahn SH, Park JY, Kim do Y, Chon CY, et al. (2008) Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan((R))) before curative resection of hepatocellular carcinoma: a pilot study. Hepatol Int. 2: 471-477. Epub 2008 Sep 2009.
8. van den Broek MA, Olde Damink SW, Dejong CH, Lang H, Malago M, et al. (2008) Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int. 28: 767-780. (Pubitemid 351818638)
9. Friedman LS (2010) Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc. 121: 192-204; discussion 205.
10. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, et al. (2003) Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 29: 1705-1713. (Pubitemid 38091720)
11. Jung KS, Kim SU (2012) Clinical applications of transient elastography. Clin Mol Hepatol. 18: 163-173. doi: 110.3350/cmh.2012.3318.3352.3163. Epub 2012 Jun 3326.
12. Jung KS, Kim SU, Ahn SH, Park YN, Kim do Y, et al. (2011) Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology. 53: 885-894. doi: 810.1002/hep.24121. Epub 22011 Feb 24111.
13. Chon YE, Jung ES, Park JY, Kim do Y, Ahn SH, et al. (2012) The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B. J Clin Gastroenterol. 46: 518-525. doi: 510.1097/MCG.1090b1013e31825079f31825071
14. Kim SU, Lee JH, Kim do Y, Ahn SH, Jung KS, et al. (2012) Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One. 7: e36676. doi: 36610.31371/journal.pone. 0036676. Epub 0032012 May 0036674.
15. Wong JS, Wong GL, Chan AW, Wong VW, Cheung YS, et al. (2013) Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes. Ann Surg. 257: 922-928. doi: 910.1097/SLA.1090- b1013e318269d318262ec
16. Jung KS, Kim SU, Choi GH, Park JY, Park YN, et al. (2012) Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan(R)). Ann Surg Oncol. 19: 4278-4286. doi: 4210.1245/s10434-10012-12422-10433. Epub 12012 Jul 10433.
17. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology. 53: 1020-1022. doi: 1010.1002/hep.24199
18. Makuuchi M, Sano K (2004) The surgical approach to HCC: our progress and results in Japan. Liver Transpl. 10: S46-52. (Pubitemid 38240100)
19. Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, et al. (1996) Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology. 111: 720-726. (Pubitemid 26293238)
20. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7: 462-503.
21. Kanai T, Hirohashi S, Upton MP, Noguchi M, Kishi K, et al. (1987) Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 60: 810-819. (Pubitemid 17131919)
22. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, et al. (2010) AJCC cancer staging handbook. New York: Springer-Verlag. 237-245 p.
23. Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 24: 289-293. (Pubitemid 26260021)
24. Wu JC, Huang YH, Chau GY, Su CW, Lai CR, et al. (2009) Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol. 51: 890-897. doi: 810.1016/j.jhep.2009.1007.1009. Epub 2009 Jul 1023.
25. Mazzaferro V, Romito R, Schiavo M, Mariani L, Camerini T, et al. (2006) Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology. 44: 1543-1554. (Pubitemid 44970357)
26. Huang X, Wei W, Ya N, Zeng J, Zeng Y, et al. (2013) A mathematical model to predict short-term recurrence and metastasis of primary hepatocellular carcinoma larger than 10 cm in diameter. Hepatogastroenterology. 60: 225-230. doi: 210.5754/hge
27. Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS (2002) Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol. 8: 237-242.
28. Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, et al. (1994) Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology. 106: 1618-1624. (Pubitemid 24163135)
29. Woo HG, Park ES, Cheon JH, Kim JH, Lee JS, et al. (2008) Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma. Clin Cancer Res. 14: 2056-2064. doi: 2010.1158/1078-0432.CCR-2007-1473
30. Ng IO, Lai EC, Fan ST, Ng MM, So MK (1995) Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients. Cancer. 76: 2443-2448.
31. Ko S, Kanehiro H, Hisanaga M, Nagao M, Ikeda N, et al. (2002) Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg. 89: 57-62. (Pubitemid 34031308)
32. Hanazaki K, Matsushita A, Nakagawa K, Misawa R, Amano J (2005) Risk factors of intrahepatic recurrence after curative resection of hepatocellular carcinoma. Hepatogastroenterology. 52: 580-586. (Pubitemid 40469472)
33. Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, et al. (1996) Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. Ann Surg. 224: 591-595. (Pubitemid 26384881)
34. Oliveri F, Coco B, Ciccorossi P, Colombatto P, Romagnoli V, et al. (2008) Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J Gastroenterol. 14: 6154-6162.
35. Kim SU, Kim JK, Park YN, Han KH (2012) Discordance between liver biopsy and Fibroscan(R) in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation. PLoS One. 7: e32233. doi: 32210.31371/journal.pone.0032233. Epub 0032012 Feb 0032223.
36. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, et al. (1996) Recurrence of hepatocellular carcinoma after surgery. Br J Surg. 83: 1219-1222. (Pubitemid 26290448)
37. Li T, Qin LX, Gong X, Zhou J, Sun HC, et al. (2013) Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection. Cancer. 119: 126-135. doi: 110.1002/cncr.27697. Epub 22012 Jun 27626.
38. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, et al. (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243: 229-235. (Pubitemid 43185442)
39. Cheong JY, Kim DJ, Hwang SG, Yang JM, Kim YB, et al. (2011) Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels. Liver Int. 31: 1352-1358. doi: 1310.1111/j.1478-3231.2011.02570.x. Epub 02011 Jun 02523.
40. Sato F, Hatano E, Kitamura K, Myomoto A, Fujiwara T, et al. (2011) MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria. PLoS One. 6: e16435. doi: 16410.11371/journal.pone.0016435
41. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, et al. (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med. 359: 1995-2004. doi: 1910.1056/NEJMoa0804525. Epub 0802008 Oct 0804515.